Emilie Denicolaï
Affiliations: | Aix-Marseille University |
Area:
Glioblastomas, Heterogeneity, Treatment, Proscillaridin A, Tumor location, Cancer stem cell, A2b5, ST8Sia IIIGoogle:
"Emilie Denicolaï"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Dominique Figarella-Branger | grad student | 2015 | Aix-Marseille University | |
| (Hétérogénéité des glioblastomes et mise en évidence de nouvelles approches thérapeutiques) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Birnbaum DJ, Picard M, Da Costa Q, et al. (2023) PVRIG Expression Is an Independent Prognostic Factor and a New Potential Target for Immunotherapy in Hepatocellular Carcinoma. Cancers. 15 |
| Chanez B, Appay R, Guille A, et al. (2022) Genomic analysis of paired IDHwt glioblastomas reveals recurrent alterations of MPDZ at relapse after radiotherapy and chemotherapy. Journal of the Neurological Sciences. 436: 120207 |
| Lopresti A, Acquaviva C, Boudin L, et al. (2022) Identification of Atypical Circulating Tumor Cells with Prognostic Value in Metastatic Breast Cancer Patients. Cancers. 14 |
| Jiguet-Jiglaire C, Boissonneau S, Denicolai E, et al. (2022) Plasmatic MMP9 released from tumor-infiltrating neutrophils is predictive for bevacizumab efficacy in glioblastoma patients: an AVAglio ancillary study. Acta Neuropathologica Communications. 10: 1 |
| Baeza-Kallee N, Bergès R, Soubéran A, et al. (2019) Glycolipids Recognized by A2B5 Antibody Promote Proliferation, Migration, and Clonogenicity in Glioblastoma Cells. Cancers. 11 |
| Berges R, Denicolai E, Tchoghandjian A, et al. (2018) Proscillaridin A exerts anti-tumor effects through GSK3β activation and alteration of microtubule dynamics in glioblastoma. Cell Death & Disease. 9: 984 |
| Tabouret E, Denicolai E, Delfino C, et al. (2016) Changes in PlGF and MET-HGF expressions in paired initial and recurrent glioblastoma. Journal of Neuro-Oncology. 130: 431-437 |
| Denicolaï E, Tabouret E, Colin C, et al. (2016) Molecular heterogeneity of glioblastomas: does location matter? Oncotarget. 7: 902-13 |
| Tabouret E, Tchoghandjian A, Denicolai E, et al. (2015) Recurrence of glioblastoma after radio-chemotherapy is associated with an angiogenic switch to the CXCL12-CXCR4 pathway. Oncotarget. 6: 11664-75 |
| Denicolaï E, Baeza-Kallee N, Tchoghandjian A, et al. (2014) Proscillaridin A is cytotoxic for glioblastoma cell lines and controls tumor xenograft growth in vivo. Oncotarget. 5: 10934-48 |